Map locates $43.5 million

Map Pharmaceuticals Inc. (NASDAQ:MAPP) raised $43.5 million through the sale of 3 million shares at $14.50 per share in a follow-on underwritten by Lazard and Wedbush. Map plans to submit an NDA next ...